Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

May 2012 - FRMC

05/24/2012

Tori Socha

Tori Socha
San Francisco—Over the past year, there has been a slowing in the rate of growth of expenditures for drugs. At a Contemporary Issues session at the AMCP meeting, Douglas Long, MBA, vice president, industry relations, at IMS Health, Inc.,...
San Francisco—Over the past year, there has been a slowing in the rate of growth of expenditures for drugs. At a Contemporary Issues session at the AMCP meeting, Douglas Long, MBA, vice president, industry relations, at IMS Health, Inc.,...
San Francisco—Over the past...
05/24/2012
First Report Managed Care
05/24/2012

Kevin L. Carter

Kevin L. Carter
San Francisco—Rheumatoid arthritis (RA) is a chronic, inflammatory disorder characterized by pain, progressive disability due to inflammation, and joint destruction. Patients with RA often face daunting economic and comorbid burdens. Most...
San Francisco—Rheumatoid arthritis (RA) is a chronic, inflammatory disorder characterized by pain, progressive disability due to inflammation, and joint destruction. Patients with RA often face daunting economic and comorbid burdens. Most...
San Francisco—Rheumatoid...
05/24/2012
First Report Managed Care
05/24/2012

Kevin L. Carter

Kevin L. Carter
San Francisco—Jenny Gaffney, a senior manager with Avalere Health in Washington, said at the AMCP meeting that over the past few years comparative effectiveness research (CER) has been utilized increasingly by states looking to improve the...
San Francisco—Jenny Gaffney, a senior manager with Avalere Health in Washington, said at the AMCP meeting that over the past few years comparative effectiveness research (CER) has been utilized increasingly by states looking to improve the...
San Francisco—Jenny Gaffney, a...
05/24/2012
First Report Managed Care
05/24/2012

Mary Mihalovic

Mary Mihalovic
San Francisco—Pharmacy and Therapeutics (P&T) committees have evolved considerably with the demand for evidence-based decisions, according to information presented by Chryss MacGowan, RPh, director, pharmacy services managed care, Denver...
San Francisco—Pharmacy and Therapeutics (P&T) committees have evolved considerably with the demand for evidence-based decisions, according to information presented by Chryss MacGowan, RPh, director, pharmacy services managed care, Denver...
San Francisco—Pharmacy and...
05/24/2012
First Report Managed Care
05/24/2012

Jill Sederstrom

Jill Sederstrom
San Francisco—A specialty pharmacy jointly owned by a regional health plan and an outside entity can be a successful partnership with high satisfaction, but the risk and operational implications associated with the venture should also be...
San Francisco—A specialty pharmacy jointly owned by a regional health plan and an outside entity can be a successful partnership with high satisfaction, but the risk and operational implications associated with the venture should also be...
San Francisco—A specialty...
05/24/2012
First Report Managed Care
05/24/2012

Tori Socha

Tori Socha
San Francisco—It is estimated that diabetes affects 7.5% to 7.9% of Americans and the estimated annual economic burden of type 2 diabetes in the United States is $159.5 billion. Patient outcomes are affected by various factors, including the...
San Francisco—It is estimated that diabetes affects 7.5% to 7.9% of Americans and the estimated annual economic burden of type 2 diabetes in the United States is $159.5 billion. Patient outcomes are affected by various factors, including the...
San Francisco—It is estimated...
05/24/2012
First Report Managed Care
05/24/2012

Kevin L. Carter

Kevin L. Carter
San Francisco—“With the possibility of radical changes in the way pharmacy benefits are administered and delivered, the development of electronic prior authorization (ePA) has reached an inflection point, and the industry needs to work...
San Francisco—“With the possibility of radical changes in the way pharmacy benefits are administered and delivered, the development of electronic prior authorization (ePA) has reached an inflection point, and the industry needs to work...
San Francisco—“With the...
05/24/2012
First Report Managed Care
05/24/2012

Mary Mihalovic

Mary Mihalovic
San Francisco—The passing of the Patient Protection and Affordable Care Act (ACA) is presenting increasing challenges for managed Medicaid programs, which have already experienced steady growth decade by decade, according to information...
San Francisco—The passing of the Patient Protection and Affordable Care Act (ACA) is presenting increasing challenges for managed Medicaid programs, which have already experienced steady growth decade by decade, according to information...
San Francisco—The passing of the...
05/24/2012
First Report Managed Care
05/24/2012

Kevin L. Carter

Kevin L. Carter
San Francisco—Gout affects as many as 5 million people in the United States and is the most common cause of inflammatory arthritis for men >40 years of age in the US. Traditionally, the goals of treatment for this condition have been to...
San Francisco—Gout affects as many as 5 million people in the United States and is the most common cause of inflammatory arthritis for men >40 years of age in the US. Traditionally, the goals of treatment for this condition have been to...
San Francisco—Gout affects as...
05/24/2012
First Report Managed Care

News

News
05/24/2012

Jill Sederstrom

Jill Sederstrom
San Francisco—A retrospective study of patients with multiple sclerosis (MS) found that nonadherence to disease-modifying drugs (DMDs) was associated with younger age, a history of a hospitalization or emergency department (ED) visits, and...
San Francisco—A retrospective study of patients with multiple sclerosis (MS) found that nonadherence to disease-modifying drugs (DMDs) was associated with younger age, a history of a hospitalization or emergency department (ED) visits, and...
San Francisco—A retrospective...
05/24/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement